HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1601	17931 Niewiadomska G, Baksalerska-Pazera M, Lenarcik I, Riedel G Compartmental protein expression of Tau, GSK-3 beta and TrkA in cholinergic neurons of aged rats JOURNAL OF NEURAL TRANSMISSION. 2006 NOV; 113 (11): 1733-1746	1	6	35	76
1602	18034 Boeve BF A review of the non-Alzheimer dementias JOURNAL OF CLINICAL PSYCHIATRY. 2006 DEC; 67 (12): 1985-2001	3	5	35	98
1603	19199 Reynolds MR, Berry RW, Binder LI Nitration in neurodegeneration: Deciphering the "hows" "nYs" BIOCHEMISTRY. 2007 JUN 26; 46 (25): 7325-7336	16	35	35	100
1604	19207 Bian H, Grossman M Frontotemporal lobar degeneration: recent progress in antemortem diagnosis ACTA NEUROPATHOLOGICA. 2007 JUL; 114 (1): 23-29	6	7	35	54
1605	19567 Bharathi, Bharathi Indi SS, Rao KSJ Copper- and iron-induced differential fibril formation in alpha- synuclein: TEM study NEUROSCIENCE LETTERS. 2007 SEP 7; 424 (2): 78-82	7	0	35	44
1606	19644 Hedlund E, Hefferan MP, Marsala M, Isacson O Cell therapy and stem cells in animal models of motor neuron disorders EUROPEAN JOURNAL OF NEUROSCIENCE. 2007 OCT; 26 (7): 1721-1737	4	25	35	223
1607	19806 Hodges JR, Patterson K Semantic dementia: a unique clinicopathological syndrome LANCET NEUROLOGY. 2007 NOV; 6 (11): 1004-1014	21	50	35	123
1608	19956 Steinhilb ML, Dias-Santagata D, Fulga TA, Felch DL, Feany MB Tau phosphorylation sites work in concert to promote neurotoxicity in vivo MOLECULAR BIOLOGY OF THE CELL. 2007 DEC; 18 (12): 5060-5068	30	37	35	46
1609	20141 Bretteville A, Planel E Tau aggregates: Toxic, inert, or protective species? JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 431-436	10	12	35	56
1610	20291 Nakamura T, Lipton SA Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases ANTIOXIDANTS & REDOX SIGNALING. 2008 JAN; 10 (1): 87-101	7	34	35	154
#	Date / Author / Journal	LCS	GCS	LCR	CR
1611	20358 Schapira AHV Mitochondria in the aetiology and pathogenesis of Parkinson's disease LANCET NEUROLOGY. 2008 JAN; 7 (1): 97-109	37	144	35	164
1612	20774 Abdipranoto A, Wu S, Stayte S, Vissel B The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2008 APR; 7 (2): 187-210	3	12	35	450
1613	20949 Basurto-Islas G, Luna-Munoz J, Guillozet-Bongaarts AL, Binder LI, Mena R, et al. Accumulation of aspartic Acid(421)- and glutamic Acid(391)-Cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 MAY; 67 (5): 470-483	7	10	35	92
1614	21134 Bar-On P, Crews L, Koob AO, Mizuno H, Adame A, et al. Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease JOURNAL OF NEUROCHEMISTRY. 2008 JUN; 105 (5): 1656-1667	9	18	35	71
1615	21372 Zhang NY, Tang ZY, Liu CW alpha-synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation - Understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 JUL 18; 283 (29): 20288-20298	11	17	35	69
1616	21767 Kuwahara T, Koyama A, Koyama S, Yoshina S, Ren CH, et al. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C.elegans HUMAN MOLECULAR GENETICS. 2008 OCT 1; 17 (19): 2997-3009	16	22	35	68
1617	22116 Croot K Progressive language impairments: Definitions, diagnoses, and prognoses APHASIOLOGY. 2009; 23 (2): 302-326	0	1	35	103
1618	22308 Lu XH BAC TO DEGENERATION: BACTERIAL ARTIFICIAL CHROMOSOME (BAC)-MEDIATED TRANSGENESIS FOR MODELING BASAL GANGLIA NEURODEGENERATIVE DISORDERS NOVEL APPROACHES TO STUDYING BASAL GANGLIA AND RELATED NEUROPSYCHIATRIC DISODERS. 2009; 89: 37-56	0	0	35	87
1619	22573 LaPointe NE, Morfini G, Pigino G, Gaisina IN, Kozikowski AP, et al. The Amino Terminus of Tau Inhibits Kinesin-Dependent Axonal Transport: Implications for Filament Toxicity JOURNAL OF NEUROSCIENCE RESEARCH. 2009 FEB 1; 87 (2): 440-451	13	20	35	60
1620	22722 Buckingham SD, Jones AK, Brown LA, Sattelle DB Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection PHARMACOLOGICAL REVIEWS. 2009 MAR; 61 (1): 39-61	0	18	35	248
#	Date / Author / Journal	LCS	GCS	LCR	CR
1621	23012 McFarland NR, Fan ZY, Xu K, Schwarzschild MA, Feany MB, et al. alpha-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 MAY; 68 (5): 515-524	8	7	35	52
1622	23097 Rospigliosi CC, McClendon S, Schmid AW, Ramlall TF, Barre P, et al. E46K Parkinson's-Linked Mutation Enhances C-Terminal-to-N-Terminal Contacts in alpha-Synuclein JOURNAL OF MOLECULAR BIOLOGY. 2009 MAY 22; 388 (5): 1022-1032	6	7	35	55
1623	23132 Lopes JP, Oliveira CR, Agostinho P Cell Cycle Re-Entry in Alzheimer's Disease: A Major Neuropathological Characteristic? CURRENT ALZHEIMER RESEARCH. 2009 JUN; 6 (3): 205-212	1	4	35	128
1624	23598 Josephs KA, Stroh A, Dugger B, Dickson DW Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes ACTA NEUROPATHOLOGICA. 2009 SEP; 118 (3): 349-358	10	10	35	38
1625	23828 Song YJC, Halliday GM, Holton JL, Lashley T, O'Sullivan SS, et al. Degeneration in Different Parkinsonian Syndromes Relates to Astrocyte Type and Astrocyte Protein Expression JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 OCT; 68 (10): 1073-1083	3	4	35	63
1626	23898 Pesiridis GS, Lee VMY, Trojanowski JQ Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis HUMAN MOLECULAR GENETICS. 2009 OCT 15; 18: R156-R162	21	24	35	68
1627	23962 Kurz A, Perneczky R Neurobiology of cognitive disorders CURRENT OPINION IN PSYCHIATRY. 2009 NOV; 22 (6): 546-551	0	4	35	56
1628	24111 Muskulus M, Scheenstra AEH, Braakman N, Dijkstra J, Verduyn-Lunel S, et al. Prospects for Early Detection of Alzheimer's Disease from Serial MR Images in Transgenic Mouse Models CURRENT ALZHEIMER RESEARCH. 2009 DEC; 6 (6): 503-518	1	4	35	140
1629	24340 Matsuda N, Tanaka K Does Impairment of the Ubiquitin-Proteasome System or the Autophagy- Lysosome Pathway Predispose Individuals to Neurodegenerative Disorders such as Parkinson's Disease? JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (1): 1-9	2	7	35	76
1630	24595 Kaye ED, Petrovic-Poljak A, Verhoeff NPLG, Freedman M Frontotemporal Dementia and Pharmacologic Interventions JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2010 WIN; 22 (1): 19-29	2	2	35	98
#	Date / Author / Journal	LCS	GCS	LCR	CR
1631	24858 Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo HUMAN MOLECULAR GENETICS. 2010 FEB 15; 19 (4): 671-683	22	24	35	69
1632	24879 Suk JE, Lokappa SB, Ulmer TS The Clustering and Spatial Arrangement of beta-Sheet Sequence, but Not Order, Govern alpha-Synuclein Fibrillogenesis BIOCHEMISTRY. 2010 FEB 23; 49 (7): 1533-1540	0	0	35	58
1633	24918 Luebke J, Barbas H, Peters A Effects of normal aging on prefrontal area 46 in the rhesus monkey BRAIN RESEARCH REVIEWS. 2010 MAR; 62 (2): 212-232	0	2	35	206
1634	25213 Yu ZW, Xu XH, Xiang ZH, Zhou JF, Zhang ZH, et al. Nitrated alpha-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats PLOS ONE. 2010 APR 8; 5 (4): Art. No. e9956	0	0	35	63
1635	25387 Frade JM, Lopez-Sanchez N A novel hypothesis for Alzheimer's disease based on neuronal tetraploidy induced by p75(NTR) CELL CYCLE. 2010 MAY 15; 9 (10): 1934-1941	0	0	35	165
1636	25576 Bigio EH, Mishra M, Hatanpaa KJ, White CL, Johnson N, et al. TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease ACTA NEUROPATHOLOGICA. 2010 JUL; 120 (1): 43-54	1	1	35	44
1637	25612 Silani V, Calzarossa C, Cova L, Ticozzi N Stem Cells in Amyotrophic Lateral Sclerosis: Motor Neuron Protection or Replacement? CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 314-324	0	1	35	153
1638	25735 Tanji K, Mori F, Mimura J, Itoh K, Kakita A, et al. Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice ACTA NEUROPATHOLOGICA. 2010 AUG; 120 (2): 145-154	1	1	35	41
1639	25994 Wills J, Jones J, Haggerty T, Duka V, Joyce JN, et al. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia EXPERIMENTAL NEUROLOGY. 2010 SEP; 225 (1): 210-218	0	0	35	42
1640	26215 Ali YO, Kitay BM, Zhai RG Dealing with Misfolded Proteins: Examining the Neuroprotective Role of Molecular Chaperones in Neurodegeneration MOLECULES. 2010 OCT; 15 (10): 6859-6887	0	0	35	210
#	Date / Author / Journal	LCS	GCS	LCR	CR
1641	26248 Duennwald ML, Shorter J Countering amyloid polymorphism and drug resistance with minimal drug cocktails PRION. 2010 OCT-DEC; 4 (4): 244-251	0	0	35	108
1642	26312 Kim SH, Shanware NP, Bowler MJ, Tibbetts RS Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 OCT 29; 285 (44): 34097-34105	3	3	35	44
1643	26366 Raggi A, Ferri R Sleep disorders in neurodegenerative diseases EUROPEAN JOURNAL OF NEUROLOGY. 2010 NOV; 17 (11): 1326-1338	0	0	35	154
1644	26646 Zibaee S, Fraser G, Jakes R, Owen D, Serpell LC, et al. Human beta-Synuclein Rendered Fibrillogenic by Designed Mutations JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 DEC 3; 285 (49): 38555-38567	0	0	35	80
1645	26819 Braga CA, Follmer C, Palhano FL, Khattar E, Freitas MS, et al. The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of alpha-Synuclein Aggregation Leading to the Formation of Nontoxic Species JOURNAL OF MOLECULAR BIOLOGY. 2011 JAN 7; 405 (1): 254-273	0	0	35	74
1646	26888 Sau D, Rusmini P, Crippa V, Onesto E, Bolzoni E, et al. Dysregulation of axonal transport and motorneuron diseases BIOLOGY OF THE CELL. 2011 FEB; 103 (2): 87-107	0	0	35	187
1647	26896 Harris RA, Amor S Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2011 FEB; 10 (1): 82-107	0	0	35	334
1648	26926 Ittner LM, Gotz J Amyloid-beta and tau - a toxic pas de deux in Alzheimer's disease NATURE REVIEWS NEUROSCIENCE. 2011 FEB; 12 (2): 67-72	0	0	35	66
1649	3467 SCHMIDT ML, DIDARIO AG, OTVOS L, HOSHI N, KANT JA, et al. PLAQUE-ASSOCIATED NEURONAL PROTEINS - A RECURRENT MOTIF IN NEURITIC AMYLOID DEPOSITS THROUGHOUT DIVERSE CORTICAL AREAS OF THE ALZHEIMERS-DISEASE BRAIN EXPERIMENTAL NEUROLOGY. 1994 DEC; 130 (2): 311-322	28	27	34	66
1650	5894 Breen KC, Coughlan CM, Hayes FD The role of glycoproteins in neural development, function, and disease MOLECULAR NEUROBIOLOGY. 1998 APR; 16 (2): 163-220	2	28	34	532
#	Date / Author / Journal	LCS	GCS	LCR	CR
1651	6113 Preuss U, Mandelkow EM Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease EUROPEAN JOURNAL OF CELL BIOLOGY. 1998 JUL; 76 (3): 176-184	19	34	34	82
1652	6743 Cookson MR, Shaw PJ Oxidative stress and motor neurone disease BRAIN PATHOLOGY. 1999 JAN; 9 (1): 165-186	31	119	34	147
1653	6984 Ekinci FJ, Shea TB Hyperactivation of mitogen-activated protein kinase increases phospho- tau immunoreactivity within human neuroblastoma: Additive and synergistic influence of alteration of additional kinase activities CELLULAR AND MOLECULAR NEUROBIOLOGY. 1999 APR; 19 (2): 249-260	6	13	34	58
1654	7479 Julien JP Neurofilament functions in health and disease CURRENT OPINION IN NEUROBIOLOGY. 1999 OCT; 9 (5): 554-560	52	145	34	51
1655	7807 Hutton M, Lovestone S, Heutink P, Pickering-Brown S, Yen SH Missense and splice site mutations in Tau associated with FTDP-17 multiple pathogenic mechanisms FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 29-51	0	0	34	51
1656	8612 Hartig W, Klein C, Brauer K, Schuppel KF, Arendt T, et al. Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders ACTA NEUROPATHOLOGICA. 2000 SEP; 100 (3): 305-312	13	19	34	55
1657	8643 Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, et al. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2000 SEP; 59 (9): 830-841	70	70	34	52
1658	8770 Eidenmuller J, Fath T, Hellwig A, Reed J, Sontag E, et al. Structural and functional implications of tau hyperphosphorylation: Information from phosphorylation-mimicking mutated tau proteins BIOCHEMISTRY. 2000 OCT 31; 39 (43): 13166-13175	39	59	34	59
1659	8851 Jo EJ, McLaurin J, Yip CM, St George-Hyslop P, Fraser PE alpha-synuclein membrane interactions and lipid specificity JOURNAL OF BIOLOGICAL CHEMISTRY. 2000 NOV 3; 275 (44): 34328-34334	157	196	34	61
1660	8908 O'Ferrall EK, Robertson J, Mushynski WE Inhibition of aberrant and constitutive phosphorylation of the high- molecular-mass neurofilament subunit by CEP-1347 (KT7515), an inhibitor of the stress-activated protein kinase signaling pathway JOURNAL OF NEUROCHEMISTRY. 2000 DEC; 75 (6): 2358-2367	6	14	34	70
#	Date / Author / Journal	LCS	GCS	LCR	CR
1661	8913 Nicholson SJ, Witherden AS, Hafezparast M, Martin JE, Fisher EMC Mice, the motor system, and human motor neuron pathology MAMMALIAN GENOME. 2000 DEC; 11 (12): 1041-1052	5	17	34	133
1662	8917 Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, et al. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells MOLECULAR BIOLOGY OF THE CELL. 2000 DEC; 11 (12): 4093-4104	49	49	34	43
1663	8955 Shanavas A, Papasozomenos SC tau kinases in the rat heat shock model: Possible implications for Alzheimer disease PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2000 DEC 19; 97 (26): 14139-14144	7	11	34	65
1664	9092 Mack TGA, Dayanandan R, Van Slegtenhorst M, Whone A, Hutton M, et al. Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells NEUROSCIENCE. 2001; 108 (4): 701-712	15	17	34	39
1665	9161 Bonifati V Monogenic parkinsonisms and the genetics of Parkinson's disease FUNCTIONAL NEUROLOGY. 2001 JAN-MAR; 16 (1): 35-44	0	0	34	63
1666	9201 Sherman MY, Goldberg AL Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases NEURON. 2001 JAN; 29 (1): 15-32	169	516	34	188
1667	9316 Law A, Gauthier S, Quirion R Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type BRAIN RESEARCH REVIEWS. 2001 MAR; 35 (1): 73-96	14	154	34	469
1668	9414 Masliah E, Sisk A, Mallory M, Games D Neurofibrillary pathology in transgenic mice overexpressing V717F beta- amyloid precursor protein JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2001 APR; 60 (4): 357-368	28	52	34	65
1669	9771 Eidenmuller J, Fath T, Maas T, Pool M, Sontag E, et al. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein BIOCHEMICAL JOURNAL. 2001 AUG 1; 357: 759-767	30	38	34	41
1670	10347 Liu F, Zaidi T, Iqbal K, Grundke-Iqbal I, Gong CX Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5 NEUROSCIENCE. 2002; 115 (3): 829-837	26	40	34	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
1671	10404 Takahashi M, Weidenheim KM, Dickson DW, Ksiezak-Reding H Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2002 JAN; 61 (1): 33-45	15	18	34	58
1672	10528 Lee HJ, Shin SY, Choi C, Lee YH, Lee SJ Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 FEB 15; 277 (7): 5411-5417	83	125	34	56
1673	10742 Forman MS, Schmidt ML, Kasturi S, Perl DP, Lee VMY, et al. Tau and alpha-synuclein pathology in amygdala of parkinsonism-dementia complex patients of Guam AMERICAN JOURNAL OF PATHOLOGY. 2002 MAY; 160 (5): 1725-1731	53	53	34	52
1674	10828 Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, et al. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein NEURON. 2002 MAY 16; 34 (4): 521-533	304	304	34	49
1675	11141 Rao MV, Garcia ML, Miyazaki Y, Gotow T, Yuan AD, et al. Gene replacement in mice reveals that the heavily phosphorylated tail of neurofilament heavy subunit does not affect axonal caliber or the transit of cargoes in slow axonal transport JOURNAL OF CELL BIOLOGY. 2002 AUG 19; 158 (4): 681-693	43	69	34	99
1676	11311 Burn DJ, Lee AJ Progressive supranuclear palsy: where are we now? LANCET NEUROLOGY. 2002 OCT; 1 (6): 359-369	16	46	34	127
1677	11544 Kosik KS, Ahn J, Stein R, Yeh LA Discovery of compounds that will prevent tau pathology JOURNAL OF MOLECULAR NEUROSCIENCE. 2002 DEC; 19 (3): 261-266	8	12	34	57
1678	11621 Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, et al. Parkin protects against the toxicity associated with mutant alpha- synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons NEURON. 2002 DEC 19; 36 (6): 1007-1019	170	271	34	53
1679	11631 Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, et al. Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease MOLECULAR BRAIN RESEARCH. 2002 DEC 30; 109 (1-2): 45-55	32	18	34	64
1680	12067 Gomez-Isla T, Irizarry MC, Mariash A, Cheung B, Soto O, et al. Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice NEUROBIOLOGY OF AGING. 2003 MAR-APR; 24 (2): 245-258	55	62	34	51
#	Date / Author / Journal	LCS	GCS	LCR	CR
1681	12247 Baptista MJ, O'Farrell C, Daya S, Ahmad R, Miller DW, et al. Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines JOURNAL OF NEUROCHEMISTRY. 2003 MAY; 85 (4): 957-968	28	46	34	58
1682	12292 Martinez J, Moeller I, Erdjument-Bromage H, Tempst P, Lauring B Parkinson's disease-associated alpha-synuclein is a calmodulin substrate JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 MAY 9; 278 (19): 17379-17387	13	19	34	60
1683	12329 Tolnay M, Probst A The neuropathological spectrum of neurodegenerative tauopathies IUBMB LIFE. 2003 JUN; 55 (6): 299-305	11	13	34	42
1684	12496 Norris EH, Giasson BI, Ischiropoulos H, Lee VMY Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 JUL 18; 278 (29): 27230-27240	67	72	34	45
1685	12523 Dekker MCJ, Bonifati V, van Duijn CM Parkinson's disease: piecing together a genetic jigsaw BRAIN. 2003 AUG; 126: 1722-1733	18	70	34	103
1686	13319 Li WX, Hoffman PN, Stirling W, Price DL, Lee MK Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations JOURNAL OF NEUROCHEMISTRY. 2004 JAN; 88 (2): 401-410	25	26	34	62
1687	13350 Becker EBE, Bonni A Cell cycle regulation of neuronal apoptosis in development and disease PROGRESS IN NEUROBIOLOGY. 2004 JAN; 72 (1): 1-25	10	124	34	289
1688	13634 Chirita C, Necula M, Kuret J Ligand-dependent inhibition and reversal of tau filament formation BIOCHEMISTRY. 2004 MAR 16; 43 (10): 2879-2887	39	53	34	60
1689	13679 Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E Enhanced substantia nigra mitochondrial pathology in human alpha- synuclein transgenic mice after treatment with MPTP EXPERIMENTAL NEUROLOGY. 2004 APR; 186 (2): 158-172	57	95	34	67
1690	13889 Nuscher B, Kamp F, Mehnert T, Odoy S, Haass C, et al. alpha-synuclein has a high affinity for packing defects in a bilayer membrane - A thermodynamics study JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 MAY 21; 279 (21): 21966-21975	33	55	34	76
#	Date / Author / Journal	LCS	GCS	LCR	CR
1691	13928 Forman MS Genotype-phenotype correlations in FTDP-17: does form follow function? Commentary EXPERIMENTAL NEUROLOGY. 2004 JUN; 187 (2): 229-234	4	4	34	47
1692	13960 Dalfo E, Barrachina M, Rosa JL, Ambrosio S, Ferrer I Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease NEUROBIOLOGY OF DISEASE. 2004 JUN; 16 (1): 92-97	13	18	34	64
1693	14381 Schulz JB, Falkenburger BH Neuronal pathology in Parkinson's disease CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 135-147	7	22	34	144
1694	14396 Jakowec MW, Petzinger GM 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of Parkinson's disease, with emphasis on mice and nonhuman primates COMPARATIVE MEDICINE. 2004 OCT; 54 (5): 497-513	4	31	34	253
1695	14590 Liu SJ, Zhang JY, Li HL, Fang ZY, Wang Q, et al. Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 NOV 26; 279 (48): 50078-50088	34	59	34	64
1696	14656 Zhou C, Emadi S, Sierks MR, Messer A A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein MOLECULAR THERAPY. 2004 DEC; 10 (6): 1023-1031	18	38	34	53
1697	14773 Arendt T Alzheimer's disease as a disorder of dynamic brain self-organization DEVELOPMENT, DYNAMICS AND PATHOLOGY OF NEURONAL NETWORKS: FROM MOLECULES TO FUNCTIONAL CIRCUITS. 2005; 147: 355-378	1	11	34	161
1698	14826 Mandel S, Grunblatt E, Riederer P, Amariglio N, Hirsch JJ, et al. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70 NEUROPROTECTIVE AGENTS. 2005; 1053: 356-375	21	40	34	92
1699	14962 Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW Tau, tangles, and Alzheimer's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 216-223	51	80	34	53
1700	14981 Bisaglia M, Tessari I, Pinato L, Bellanda M, Giraudo S, et al. A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles BIOCHEMISTRY. 2005 JAN 11; 44 (1): 329-339	37	56	34	83

Date / Author / Journal

LCS

GCS

LCR

1601

17931 Niewiadomska G, Baksalerska-Pazera M, Lenarcik I, Riedel G

Compartmental protein expression of Tau, GSK-3 beta and TrkA in cholinergic neurons of aged rats

JOURNAL OF NEURAL TRANSMISSION. 2006 NOV; 113 (11): 1733-1746

1602

18034 Boeve BF

A review of the non-Alzheimer dementias

JOURNAL OF CLINICAL PSYCHIATRY. 2006 DEC; 67 (12): 1985-2001

1603

19199 Reynolds MR, Berry RW, Binder LI

Nitration in neurodegeneration: Deciphering the "hows" "nYs"

BIOCHEMISTRY. 2007 JUN 26; 46 (25): 7325-7336

100

1604

19207 Bian H, Grossman M

Frontotemporal lobar degeneration: recent progress in antemortem diagnosis

ACTA NEUROPATHOLOGICA. 2007 JUL; 114 (1): 23-29

1605

19567 Bharathi, Bharathi Indi SS, Rao KSJ

Copper- and iron-induced differential fibril formation in alpha- synuclein: TEM study

NEUROSCIENCE LETTERS. 2007 SEP 7; 424 (2): 78-82

1606

19644 Hedlund E, Hefferan MP, Marsala M, Isacson O

Cell therapy and stem cells in animal models of motor neuron disorders

EUROPEAN JOURNAL OF NEUROSCIENCE. 2007 OCT; 26 (7): 1721-1737

223

1607

19806 Hodges JR, Patterson K

Semantic dementia: a unique clinicopathological syndrome

LANCET NEUROLOGY. 2007 NOV; 6 (11): 1004-1014

123

1608

19956 Steinhilb ML, Dias-Santagata D, Fulga TA, Felch DL, Feany MB

Tau phosphorylation sites work in concert to promote neurotoxicity in vivo

MOLECULAR BIOLOGY OF THE CELL. 2007 DEC; 18 (12): 5060-5068

1609

20141 Bretteville A, Planel E

Tau aggregates: Toxic, inert, or protective species?

JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 431-436

1610

20291 Nakamura T, Lipton SA

Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases

ANTIOXIDANTS & REDOX SIGNALING. 2008 JAN; 10 (1): 87-101

154

Date / Author / Journal

1611

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

LANCET NEUROLOGY. 2008 JAN; 7 (1): 97-109

144

164

1612

20774 Abdipranoto A, Wu S, Stayte S, Vissel B

The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2008 APR; 7 (2): 187-210

450

1613

20949 Basurto-Islas G, Luna-Munoz J, Guillozet-Bongaarts AL, Binder LI, Mena R, et al.

Accumulation of aspartic Acid(421)- and glutamic Acid(391)-Cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 MAY; 67 (5): 470-483

1614

21134 Bar-On P, Crews L, Koob AO, Mizuno H, Adame A, et al.

Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease

JOURNAL OF NEUROCHEMISTRY. 2008 JUN; 105 (5): 1656-1667

1615

21372 Zhang NY, Tang ZY, Liu CW

alpha-synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation - Understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis

JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 JUL 18; 283 (29): 20288-20298

1616

21767 Kuwahara T, Koyama A, Koyama S, Yoshina S, Ren CH, et al.

A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C.elegans

HUMAN MOLECULAR GENETICS. 2008 OCT 1; 17 (19): 2997-3009

1617

22116 Croot K

Progressive language impairments: Definitions, diagnoses, and prognoses

APHASIOLOGY. 2009; 23 (2): 302-326

103

1618

22308 Lu XH

BAC TO DEGENERATION: BACTERIAL ARTIFICIAL CHROMOSOME (BAC)-MEDIATED TRANSGENESIS FOR MODELING BASAL GANGLIA NEURODEGENERATIVE DISORDERS

NOVEL APPROACHES TO STUDYING BASAL GANGLIA AND RELATED NEUROPSYCHIATRIC DISODERS. 2009; 89: 37-56

1619

22573 LaPointe NE, Morfini G, Pigino G, Gaisina IN, Kozikowski AP, et al.

The Amino Terminus of Tau Inhibits Kinesin-Dependent Axonal Transport: Implications for Filament Toxicity

JOURNAL OF NEUROSCIENCE RESEARCH. 2009 FEB 1; 87 (2): 440-451

1620

22722 Buckingham SD, Jones AK, Brown LA, Sattelle DB

Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection

PHARMACOLOGICAL REVIEWS. 2009 MAR; 61 (1): 39-61

248

Date / Author / Journal

LCS

GCS

LCR

1621

23012 McFarland NR, Fan ZY, Xu K, Schwarzschild MA, Feany MB, et al.

alpha-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 MAY; 68 (5): 515-524

1622

23097 Rospigliosi CC, McClendon S, Schmid AW, Ramlall TF, Barre P, et al.

E46K Parkinson's-Linked Mutation Enhances C-Terminal-to-N-Terminal Contacts in alpha-Synuclein

JOURNAL OF MOLECULAR BIOLOGY. 2009 MAY 22; 388 (5): 1022-1032

1623

23132 Lopes JP, Oliveira CR, Agostinho P

Cell Cycle Re-Entry in Alzheimer's Disease: A Major Neuropathological Characteristic?

CURRENT ALZHEIMER RESEARCH. 2009 JUN; 6 (3): 205-212

128

1624

23598 Josephs KA, Stroh A, Dugger B, Dickson DW

Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes

ACTA NEUROPATHOLOGICA. 2009 SEP; 118 (3): 349-358

1625

23828 Song YJC, Halliday GM, Holton JL, Lashley T, O'Sullivan SS, et al.

Degeneration in Different Parkinsonian Syndromes Relates to Astrocyte Type and Astrocyte Protein Expression

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 OCT; 68 (10): 1073-1083

1626

23898 Pesiridis GS, Lee VMY, Trojanowski JQ

Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis

HUMAN MOLECULAR GENETICS. 2009 OCT 15; 18: R156-R162

1627

23962 Kurz A, Perneczky R

Neurobiology of cognitive disorders

CURRENT OPINION IN PSYCHIATRY. 2009 NOV; 22 (6): 546-551

1628

24111 Muskulus M, Scheenstra AEH, Braakman N, Dijkstra J, Verduyn-Lunel S, et al.

Prospects for Early Detection of Alzheimer's Disease from Serial MR Images in Transgenic Mouse Models

CURRENT ALZHEIMER RESEARCH. 2009 DEC; 6 (6): 503-518

140

1629

24340 Matsuda N, Tanaka K

Does Impairment of the Ubiquitin-Proteasome System or the Autophagy- Lysosome Pathway Predispose Individuals to Neurodegenerative Disorders such as Parkinson's Disease?

JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (1): 1-9

1630

24595 Kaye ED, Petrovic-Poljak A, Verhoeff NPLG, Freedman M

Frontotemporal Dementia and Pharmacologic Interventions

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2010 WIN; 22 (1): 19-29

Date / Author / Journal

LCS

GCS

LCR

1631

24858 Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, et al.

Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo

HUMAN MOLECULAR GENETICS. 2010 FEB 15; 19 (4): 671-683

1632

24879 Suk JE, Lokappa SB, Ulmer TS

The Clustering and Spatial Arrangement of beta-Sheet Sequence, but Not Order, Govern alpha-Synuclein Fibrillogenesis

BIOCHEMISTRY. 2010 FEB 23; 49 (7): 1533-1540

1633

24918 Luebke J, Barbas H, Peters A

Effects of normal aging on prefrontal area 46 in the rhesus monkey

BRAIN RESEARCH REVIEWS. 2010 MAR; 62 (2): 212-232

206

1634

25213 Yu ZW, Xu XH, Xiang ZH, Zhou JF, Zhang ZH, et al.

Nitrated alpha-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats

PLOS ONE. 2010 APR 8; 5 (4): Art. No. e9956

1635

25387 Frade JM, Lopez-Sanchez N

A novel hypothesis for Alzheimer's disease based on neuronal tetraploidy induced by p75(NTR)

CELL CYCLE. 2010 MAY 15; 9 (10): 1934-1941

165

1636

25576 Bigio EH, Mishra M, Hatanpaa KJ, White CL, Johnson N, et al.

TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease

ACTA NEUROPATHOLOGICA. 2010 JUL; 120 (1): 43-54

1637

25612 Silani V, Calzarossa C, Cova L, Ticozzi N

Stem Cells in Amyotrophic Lateral Sclerosis: Motor Neuron Protection or Replacement?

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 314-324

153

1638

25735 Tanji K, Mori F, Mimura J, Itoh K, Kakita A, et al.

Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice

ACTA NEUROPATHOLOGICA. 2010 AUG; 120 (2): 145-154

1639

25994 Wills J, Jones J, Haggerty T, Duka V, Joyce JN, et al.

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

EXPERIMENTAL NEUROLOGY. 2010 SEP; 225 (1): 210-218

1640

26215 Ali YO, Kitay BM, Zhai RG

Dealing with Misfolded Proteins: Examining the Neuroprotective Role of Molecular Chaperones in Neurodegeneration

MOLECULES. 2010 OCT; 15 (10): 6859-6887

210

Date / Author / Journal

LCS

GCS

LCR

1641

26248 Duennwald ML, Shorter J

Countering amyloid polymorphism and drug resistance with minimal drug cocktails

PRION. 2010 OCT-DEC; 4 (4): 244-251

108

1642

26312 Kim SH, Shanware NP, Bowler MJ, Tibbetts RS

Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA

JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 OCT 29; 285 (44): 34097-34105

1643

26366 Raggi A, Ferri R

Sleep disorders in neurodegenerative diseases

EUROPEAN JOURNAL OF NEUROLOGY. 2010 NOV; 17 (11): 1326-1338

154

1644

26646 Zibaee S, Fraser G, Jakes R, Owen D, Serpell LC, et al.

Human beta-Synuclein Rendered Fibrillogenic by Designed Mutations

JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 DEC 3; 285 (49): 38555-38567

1645

26819 Braga CA, Follmer C, Palhano FL, Khattar E, Freitas MS, et al.

The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of alpha-Synuclein Aggregation Leading to the Formation of Nontoxic Species

JOURNAL OF MOLECULAR BIOLOGY. 2011 JAN 7; 405 (1): 254-273

1646

26888 Sau D, Rusmini P, Crippa V, Onesto E, Bolzoni E, et al.

Dysregulation of axonal transport and motorneuron diseases

BIOLOGY OF THE CELL. 2011 FEB; 103 (2): 87-107

187

1647

26896 Harris RA, Amor S

Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2011 FEB; 10 (1): 82-107

334

1648

26926 Ittner LM, Gotz J

Amyloid-beta and tau - a toxic pas de deux in Alzheimer's disease

NATURE REVIEWS NEUROSCIENCE. 2011 FEB; 12 (2): 67-72

1649

3467 SCHMIDT ML, DIDARIO AG, OTVOS L, HOSHI N, KANT JA, et al.

PLAQUE-ASSOCIATED NEURONAL PROTEINS - A RECURRENT MOTIF IN NEURITIC AMYLOID DEPOSITS THROUGHOUT DIVERSE CORTICAL AREAS OF THE ALZHEIMERS-DISEASE BRAIN

EXPERIMENTAL NEUROLOGY. 1994 DEC; 130 (2): 311-322

1650

5894 Breen KC, Coughlan CM, Hayes FD

The role of glycoproteins in neural development, function, and disease

MOLECULAR NEUROBIOLOGY. 1998 APR; 16 (2): 163-220

532

Date / Author / Journal

LCS

GCS

LCR

1651

6113 Preuss U, Mandelkow EM

Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease

EUROPEAN JOURNAL OF CELL BIOLOGY. 1998 JUL; 76 (3): 176-184

1652

6743 Cookson MR, Shaw PJ

Oxidative stress and motor neurone disease

BRAIN PATHOLOGY. 1999 JAN; 9 (1): 165-186

119

147

1653

6984 Ekinci FJ, Shea TB

Hyperactivation of mitogen-activated protein kinase increases phospho- tau immunoreactivity within human neuroblastoma: Additive and synergistic influence of alteration of additional kinase activities

CELLULAR AND MOLECULAR NEUROBIOLOGY. 1999 APR; 19 (2): 249-260

1654

7479 Julien JP

Neurofilament functions in health and disease

CURRENT OPINION IN NEUROBIOLOGY. 1999 OCT; 9 (5): 554-560

145

1655

7807 Hutton M, Lovestone S, Heutink P, Pickering-Brown S, Yen SH

Missense and splice site mutations in Tau associated with FTDP-17 multiple pathogenic mechanisms

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 29-51

1656

8612 Hartig W, Klein C, Brauer K, Schuppel KF, Arendt T, et al.

Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders

ACTA NEUROPATHOLOGICA. 2000 SEP; 100 (3): 305-312

1657

8643 Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, et al.

Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2000 SEP; 59 (9): 830-841

1658

8770 Eidenmuller J, Fath T, Hellwig A, Reed J, Sontag E, et al.

Structural and functional implications of tau hyperphosphorylation: Information from phosphorylation-mimicking mutated tau proteins

BIOCHEMISTRY. 2000 OCT 31; 39 (43): 13166-13175

1659

8851 Jo EJ, McLaurin J, Yip CM, St George-Hyslop P, Fraser PE

alpha-synuclein membrane interactions and lipid specificity

JOURNAL OF BIOLOGICAL CHEMISTRY. 2000 NOV 3; 275 (44): 34328-34334

157

196

1660

8908 O'Ferrall EK, Robertson J, Mushynski WE

Inhibition of aberrant and constitutive phosphorylation of the high- molecular-mass neurofilament subunit by CEP-1347 (KT7515), an inhibitor of the stress-activated protein kinase signaling pathway

JOURNAL OF NEUROCHEMISTRY. 2000 DEC; 75 (6): 2358-2367

Date / Author / Journal

LCS

GCS

LCR

1661

8913 Nicholson SJ, Witherden AS, Hafezparast M, Martin JE, Fisher EMC

Mice, the motor system, and human motor neuron pathology

MAMMALIAN GENOME. 2000 DEC; 11 (12): 1041-1052

133

1662

8917 Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, et al.

Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells

MOLECULAR BIOLOGY OF THE CELL. 2000 DEC; 11 (12): 4093-4104

1663

8955 Shanavas A, Papasozomenos SC

tau kinases in the rat heat shock model: Possible implications for Alzheimer disease

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2000 DEC 19; 97 (26): 14139-14144

1664

9092 Mack TGA, Dayanandan R, Van Slegtenhorst M, Whone A, Hutton M, et al.

Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells

NEUROSCIENCE. 2001; 108 (4): 701-712

1665

9161 Bonifati V

Monogenic parkinsonisms and the genetics of Parkinson's disease

FUNCTIONAL NEUROLOGY. 2001 JAN-MAR; 16 (1): 35-44

1666

9201 Sherman MY, Goldberg AL

Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases

NEURON. 2001 JAN; 29 (1): 15-32

169

516

188

1667

9316 Law A, Gauthier S, Quirion R

Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type

BRAIN RESEARCH REVIEWS. 2001 MAR; 35 (1): 73-96

154

469

1668

9414 Masliah E, Sisk A, Mallory M, Games D

Neurofibrillary pathology in transgenic mice overexpressing V717F beta- amyloid precursor protein

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2001 APR; 60 (4): 357-368

1669

9771 Eidenmuller J, Fath T, Maas T, Pool M, Sontag E, et al.

Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein

BIOCHEMICAL JOURNAL. 2001 AUG 1; 357: 759-767

1670

10347 Liu F, Zaidi T, Iqbal K, Grundke-Iqbal I, Gong CX

Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5

NEUROSCIENCE. 2002; 115 (3): 829-837

Date / Author / Journal

LCS

GCS

LCR

1671

10404 Takahashi M, Weidenheim KM, Dickson DW, Ksiezak-Reding H

Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2002 JAN; 61 (1): 33-45

1672

10528 Lee HJ, Shin SY, Choi C, Lee YH, Lee SJ

Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 FEB 15; 277 (7): 5411-5417

125

1673

10742 Forman MS, Schmidt ML, Kasturi S, Perl DP, Lee VMY, et al.

Tau and alpha-synuclein pathology in amygdala of parkinsonism-dementia complex patients of Guam

AMERICAN JOURNAL OF PATHOLOGY. 2002 MAY; 160 (5): 1725-1731

1674

10828 Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, et al.

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein

NEURON. 2002 MAY 16; 34 (4): 521-533

304

1675

11141 Rao MV, Garcia ML, Miyazaki Y, Gotow T, Yuan AD, et al.

Gene replacement in mice reveals that the heavily phosphorylated tail of neurofilament heavy subunit does not affect axonal caliber or the transit of cargoes in slow axonal transport

JOURNAL OF CELL BIOLOGY. 2002 AUG 19; 158 (4): 681-693

1676

11311 Burn DJ, Lee AJ

Progressive supranuclear palsy: where are we now?

LANCET NEUROLOGY. 2002 OCT; 1 (6): 359-369

127

1677

11544 Kosik KS, Ahn J, Stein R, Yeh LA

Discovery of compounds that will prevent tau pathology

JOURNAL OF MOLECULAR NEUROSCIENCE. 2002 DEC; 19 (3): 261-266

1678

11621 Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, et al.

Parkin protects against the toxicity associated with mutant alpha- synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons

NEURON. 2002 DEC 19; 36 (6): 1007-1019

170

271

1679

11631 Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, et al.

Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease

MOLECULAR BRAIN RESEARCH. 2002 DEC 30; 109 (1-2): 45-55

1680

12067 Gomez-Isla T, Irizarry MC, Mariash A, Cheung B, Soto O, et al.

Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice

NEUROBIOLOGY OF AGING. 2003 MAR-APR; 24 (2): 245-258

Date / Author / Journal

LCS

GCS

LCR

1681

12247 Baptista MJ, O'Farrell C, Daya S, Ahmad R, Miller DW, et al.

Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines

JOURNAL OF NEUROCHEMISTRY. 2003 MAY; 85 (4): 957-968

1682

12292 Martinez J, Moeller I, Erdjument-Bromage H, Tempst P, Lauring B

Parkinson's disease-associated alpha-synuclein is a calmodulin substrate

JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 MAY 9; 278 (19): 17379-17387

1683

12329 Tolnay M, Probst A

The neuropathological spectrum of neurodegenerative tauopathies

IUBMB LIFE. 2003 JUN; 55 (6): 299-305

1684

12496 Norris EH, Giasson BI, Ischiropoulos H, Lee VMY

Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications

JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 JUL 18; 278 (29): 27230-27240

1685

12523 Dekker MCJ, Bonifati V, van Duijn CM

Parkinson's disease: piecing together a genetic jigsaw

BRAIN. 2003 AUG; 126: 1722-1733

103

1686

13319 Li WX, Hoffman PN, Stirling W, Price DL, Lee MK

Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations

JOURNAL OF NEUROCHEMISTRY. 2004 JAN; 88 (2): 401-410

1687

13350 Becker EBE, Bonni A

Cell cycle regulation of neuronal apoptosis in development and disease

PROGRESS IN NEUROBIOLOGY. 2004 JAN; 72 (1): 1-25

124

289

1688

13634 Chirita C, Necula M, Kuret J

Ligand-dependent inhibition and reversal of tau filament formation

BIOCHEMISTRY. 2004 MAR 16; 43 (10): 2879-2887

1689

13679 Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E

Enhanced substantia nigra mitochondrial pathology in human alpha- synuclein transgenic mice after treatment with MPTP

EXPERIMENTAL NEUROLOGY. 2004 APR; 186 (2): 158-172

1690

13889 Nuscher B, Kamp F, Mehnert T, Odoy S, Haass C, et al.

alpha-synuclein has a high affinity for packing defects in a bilayer membrane - A thermodynamics study

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 MAY 21; 279 (21): 21966-21975

Date / Author / Journal

1691

Genotype-phenotype correlations in FTDP-17: does form follow function? Commentary

EXPERIMENTAL NEUROLOGY. 2004 JUN; 187 (2): 229-234

1692

13960 Dalfo E, Barrachina M, Rosa JL, Ambrosio S, Ferrer I

Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease

NEUROBIOLOGY OF DISEASE. 2004 JUN; 16 (1): 92-97

1693

14381 Schulz JB, Falkenburger BH

Neuronal pathology in Parkinson's disease

CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 135-147

144

1694

14396 Jakowec MW, Petzinger GM

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of Parkinson's disease, with emphasis on mice and nonhuman primates

COMPARATIVE MEDICINE. 2004 OCT; 54 (5): 497-513

253

1695

14590 Liu SJ, Zhang JY, Li HL, Fang ZY, Wang Q, et al.

Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 NOV 26; 279 (48): 50078-50088

1696

14656 Zhou C, Emadi S, Sierks MR, Messer A

A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein

MOLECULAR THERAPY. 2004 DEC; 10 (6): 1023-1031

1697

14773 Arendt T

Alzheimer's disease as a disorder of dynamic brain self-organization

DEVELOPMENT, DYNAMICS AND PATHOLOGY OF NEURONAL NETWORKS: FROM MOLECULES TO FUNCTIONAL CIRCUITS. 2005; 147: 355-378

161

1698

14826 Mandel S, Grunblatt E, Riederer P, Amariglio N, Hirsch JJ, et al.

Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70

NEUROPROTECTIVE AGENTS. 2005; 1053: 356-375

1699

14962 Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW

Tau, tangles, and Alzheimer's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 216-223

1700

14981 Bisaglia M, Tessari I, Pinato L, Bellanda M, Giraudo S, et al.

A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles

BIOCHEMISTRY. 2005 JAN 11; 44 (1): 329-339

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records